TELIF (Telescope Innovations) Moat Score: 2/10 (As of Jul. 02, 2026)


TELIF Telescope Innovations Corp TELIF
31 GF Score
Price $0.51
GF Value $0.37
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Telescope Innovations Moat Score?

Telescope Innovations TELIF -0.58% 31 Moat Score is 2 as of Jul. 02, 2026. GuruFocus rates TELIF with a GF Score™ of 31/100 and a GF Value™ of $0.37 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 1,400 Biotechnology companies, Telescope Innovations ranks better than 58.07% on this metric.

Telescope Innovations has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Telescope Innovations has No Moat: Telescope Innovations lacks discernible competitive advantages. It does not have market leadership, network effects, or strong brand loyalty. Its position is largely dependent on market conditions rather than inherent strengths.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Telescope Innovations might have No Moat - Very weak/transient advantages.

Telescope Innovations  (OTCPK:TELIF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Telescope Innovations Moat Score Related Terms

TELIF vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Telescope Innovations's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Telescope Innovations Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telescope Innovations's Moat Score distribution charts can be found below:

* The bar in red indicates where Telescope Innovations's Moat Score falls into.


TELIF
31GF Score
Telescope Innovations Corp TELIF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Telescope Innovations (TELIF) has a Moat Score of 2 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Telescope Innovations ranks #587 out of 1400 companies in the Biotechnology industry, placing it in the top 41.9%.
Is Telescope Innovations' Moat Score too high?
Telescope Innovations' current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Telescope Innovations' value of 2 is 0% at this industry median. Based on the distribution chart, Telescope Innovations ranks #587 out of 1400 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Telescope Innovations has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Telescope Innovations' Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Telescope Innovations ranks #587 out of 1400 companies for Moat Score. This puts Telescope Innovations in the upper half of its industry. The industry median Moat Score is 2.00. Telescope Innovations' value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,400 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Telescope Innovations's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telescope Innovations's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telescope Innovations stock overvalued right now?
Based on GuruFocus' analysis, Telescope Innovations (TELIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.37, compared to a current price of $0.51 — trading 37.1% above its estimated fair value. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Telescope Innovations' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Telescope Innovations (TELIF), the current Moat Score is 2 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telescope Innovations (TELIF) Overvalued in 2026?

Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued. The current stock price of $0.51 is trading 37.1% above its estimated GF Value™ of $0.37. GuruFocus considers Telescope Innovations to be Significantly Overvalued.

Key valuation signals for TELIF:

  • Moat Score: 2
  • GF Value™: $0.37 vs. price of $0.51 (37.1% above fair value)
  • GF Score™: 31/100 with 1 warning sign
  • Industry Position: 0% at the Biotechnology median (#587 of 1400)

No single metric tells the full story. See the TELIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Telescope Innovations Business Description

Other Exchanges J4U:GermanyTELI:Canada
Address 2386 East Mall, Suite 301, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
31GF Score

Get the complete analysis for TELIF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.51
Price
$0.37
GF Value